How do you approach adjuvant therapy for patients with advanced ovarian cancer who undergo interval debulking surgery following six cycles of neoadjuvant chemotherapy?
How does your approach vary based on residual disease left at the time of surgery? Please specify your approach for the amount of residual disease at time of surgery.
Community PollStarted
How do you approach adjuvant therapy for patients with advanced ovarian cancer who undergo optimal interval cytoreductive surgery following six cycles of neoadjuvant chemotherapy?
57 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Gynecologic Oncology · UCLA David Geffen School of Medicine/UCLA Medical Center
Answered on
If viable tumor at the time of surgery and patient has acceptable performance status then I would treat 2-3 more cycles of chemo followed by maintenance therapy. However, if no viable tumor at the time of surgery then I would forego IV chemotherapy and start maintenance postoperatively depending on ...
Join for free or sign in to see the full answer
Mednet Member
Gynecologic Oncology · Hanjani Institute
Answered on
I avoid administering 6 courses of neoadjuvant chemotherapy. I aim to only give 3-4 courses and then do the operation if the patient has responded. In my experience, giving 6 courses or more interferes with tumor biology and the tumor may develop chemoresistant cells.
Join for free or sign in to see the full answer